Ocugen IncNASDAQ:OCGN
- LAST PRICE1.1400
- TODAY'S CHANGE (%)-0.0400 (-3.3898%)
- Bid / Lots1.1300/ 15
- Ask / Lots1.1500/ 30
- Open / Previous Close1.1900 / 1.1800
- Day Range
- 52 Week Range
- Volume3,594,608
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCGN |
|---|---|---|
| 09:32 ET | 33947 | 1.1949 |
| 09:34 ET | 133382 | 1.175 |
| 09:36 ET | 31637 | 1.1894 |
| 09:38 ET | 4030 | 1.185 |
| 09:39 ET | 4532 | 1.185 |
| 09:41 ET | 29439 | 1.17 |
| 09:43 ET | 2542 | 1.1725 |
| 09:45 ET | 7414 | 1.1717 |
| 09:48 ET | 5858 | 1.17 |
| 09:50 ET | 302 | 1.17 |
| 09:52 ET | 100 | 1.1751 |
| 09:54 ET | 51882 | 1.185 |
| 09:56 ET | 24452 | 1.175 |
| 09:57 ET | 7572 | 1.1801 |
| 09:59 ET | 600 | 1.185 |
| 10:01 ET | 2872 | 1.18 |
| 10:03 ET | 9875 | 1.17 |
| 10:06 ET | 7665 | 1.17 |
| 10:08 ET | 4260 | 1.175 |
| 10:10 ET | 5033 | 1.175 |
| 10:12 ET | 7153 | 1.175 |
| 10:14 ET | 5276 | 1.175 |
| 10:15 ET | 2844 | 1.175 |
| 10:17 ET | 1100 | 1.17 |
| 10:19 ET | 9871 | 1.175 |
| 10:21 ET | 1848 | 1.18 |
| 10:24 ET | 214 | 1.175 |
| 10:26 ET | 970 | 1.1726 |
| 10:28 ET | 27146 | 1.1739 |
| 10:30 ET | 2488 | 1.17 |
| 10:32 ET | 72993 | 1.165 |
| 10:33 ET | 22956 | 1.16 |
| 10:35 ET | 19582 | 1.16 |
| 10:37 ET | 128825 | 1.155 |
| 10:39 ET | 7028 | 1.15 |
| 10:42 ET | 3874 | 1.155 |
| 10:44 ET | 20066 | 1.155 |
| 10:46 ET | 18583 | 1.155 |
| 10:48 ET | 30426 | 1.1673 |
| 10:50 ET | 505 | 1.165 |
| 10:51 ET | 2209 | 1.16 |
| 10:53 ET | 4546 | 1.165 |
| 10:55 ET | 36651 | 1.156 |
| 10:57 ET | 4601 | 1.155 |
| 11:00 ET | 5018 | 1.15 |
| 11:02 ET | 41812 | 1.16 |
| 11:04 ET | 4266 | 1.165 |
| 11:06 ET | 16414 | 1.1619 |
| 11:08 ET | 617 | 1.165 |
| 11:09 ET | 26344 | 1.16 |
| 11:11 ET | 908 | 1.16 |
| 11:13 ET | 9775 | 1.165 |
| 11:15 ET | 4400 | 1.165 |
| 11:18 ET | 23432 | 1.165 |
| 11:20 ET | 5121 | 1.165 |
| 11:22 ET | 3466 | 1.165 |
| 11:24 ET | 600 | 1.165 |
| 11:26 ET | 3358 | 1.165 |
| 11:27 ET | 10561 | 1.1601 |
| 11:29 ET | 100 | 1.1625 |
| 11:31 ET | 52656 | 1.155 |
| 11:33 ET | 57295 | 1.155 |
| 11:36 ET | 10171 | 1.155 |
| 11:38 ET | 5094 | 1.155 |
| 11:40 ET | 8364 | 1.15 |
| 11:42 ET | 239875 | 1.15 |
| 11:44 ET | 37277 | 1.15 |
| 11:45 ET | 30075 | 1.14 |
| 11:47 ET | 97211 | 1.13 |
| 11:49 ET | 9587 | 1.13 |
| 11:51 ET | 59954 | 1.135 |
| 11:54 ET | 9179 | 1.13 |
| 11:56 ET | 9665 | 1.135 |
| 11:58 ET | 80194 | 1.135 |
| 12:00 ET | 21447 | 1.1399 |
| 12:02 ET | 9785 | 1.14 |
| 12:03 ET | 3500 | 1.135 |
| 12:05 ET | 500 | 1.135 |
| 12:07 ET | 33435 | 1.145 |
| 12:09 ET | 15679 | 1.145 |
| 12:12 ET | 50388 | 1.145 |
| 12:14 ET | 39618 | 1.145 |
| 12:16 ET | 11726 | 1.145 |
| 12:18 ET | 8092 | 1.145 |
| 12:20 ET | 11119 | 1.1462 |
| 12:21 ET | 6690 | 1.1499 |
| 12:25 ET | 595 | 1.1404 |
| 12:27 ET | 812 | 1.145 |
| 12:30 ET | 4616 | 1.145 |
| 12:32 ET | 1304 | 1.145 |
| 12:34 ET | 3470 | 1.14 |
| 12:36 ET | 5580 | 1.145 |
| 12:38 ET | 8170 | 1.145 |
| 12:39 ET | 2423 | 1.15 |
| 12:41 ET | 3705 | 1.14 |
| 12:43 ET | 2145 | 1.14 |
| 12:45 ET | 124247 | 1.12 |
| 12:48 ET | 14227 | 1.1225 |
| 12:50 ET | 10325 | 1.13 |
| 12:52 ET | 4109 | 1.12 |
| 12:54 ET | 70136 | 1.13 |
| 12:56 ET | 1249 | 1.13 |
| 12:57 ET | 5433 | 1.13 |
| 12:59 ET | 100 | 1.135 |
| 01:01 ET | 18345 | 1.13 |
| 01:03 ET | 26979 | 1.13 |
| 01:06 ET | 19562 | 1.135 |
| 01:08 ET | 3405 | 1.136 |
| 01:10 ET | 11013 | 1.13 |
| 01:12 ET | 5700 | 1.135 |
| 01:14 ET | 2070 | 1.1399 |
| 01:15 ET | 131188 | 1.15 |
| 01:17 ET | 4200 | 1.1525 |
| 01:19 ET | 2752 | 1.155 |
| 01:21 ET | 650 | 1.155 |
| 01:24 ET | 4655 | 1.16 |
| 01:26 ET | 11200 | 1.15 |
| 01:28 ET | 5166 | 1.155 |
| 01:30 ET | 1453 | 1.155 |
| 01:32 ET | 719 | 1.155 |
| 01:33 ET | 6083 | 1.155 |
| 01:35 ET | 5733 | 1.155 |
| 01:37 ET | 1700 | 1.155 |
| 01:39 ET | 3802 | 1.155 |
| 01:42 ET | 4688 | 1.155 |
| 01:44 ET | 719 | 1.1503 |
| 01:46 ET | 350 | 1.16 |
| 01:48 ET | 1667 | 1.16 |
| 01:50 ET | 2051 | 1.155 |
| 01:51 ET | 1319 | 1.155 |
| 01:53 ET | 14105 | 1.16 |
| 01:55 ET | 1369 | 1.1565 |
| 01:57 ET | 118812 | 1.166 |
| 02:00 ET | 8278 | 1.165 |
| 02:02 ET | 11747 | 1.17 |
| 02:04 ET | 13708 | 1.16 |
| 02:06 ET | 41131 | 1.15 |
| 02:08 ET | 2910 | 1.1533 |
| 02:09 ET | 1626 | 1.15 |
| 02:11 ET | 4924 | 1.1501 |
| 02:13 ET | 1143 | 1.15 |
| 02:15 ET | 7623 | 1.15 |
| 02:18 ET | 100 | 1.16 |
| 02:20 ET | 7806 | 1.15 |
| 02:22 ET | 11400 | 1.15 |
| 02:24 ET | 1400 | 1.15 |
| 02:26 ET | 2000 | 1.15 |
| 02:27 ET | 700 | 1.155 |
| 02:29 ET | 1300 | 1.16 |
| 02:31 ET | 1728 | 1.15 |
| 02:33 ET | 1450 | 1.1596 |
| 02:36 ET | 4393 | 1.154 |
| 02:38 ET | 2961 | 1.155 |
| 02:40 ET | 626 | 1.1556 |
| 02:42 ET | 1200 | 1.155 |
| 02:44 ET | 100 | 1.16 |
| 02:45 ET | 8001 | 1.15 |
| 02:47 ET | 200 | 1.16 |
| 02:49 ET | 3110 | 1.16 |
| 02:51 ET | 2283 | 1.1597 |
| 02:54 ET | 2245 | 1.155 |
| 02:56 ET | 3385 | 1.16 |
| 02:58 ET | 2801 | 1.155 |
| 03:00 ET | 400 | 1.16 |
| 03:02 ET | 29736 | 1.1638 |
| 03:03 ET | 22633 | 1.155 |
| 03:05 ET | 55224 | 1.1499 |
| 03:07 ET | 2751 | 1.14 |
| 03:09 ET | 1803 | 1.14 |
| 03:12 ET | 4447 | 1.14 |
| 03:14 ET | 1710 | 1.145 |
| 03:16 ET | 5631 | 1.14 |
| 03:18 ET | 5597 | 1.14 |
| 03:20 ET | 5992 | 1.14 |
| 03:21 ET | 8502 | 1.14 |
| 03:23 ET | 3046 | 1.14 |
| 03:25 ET | 1400 | 1.14 |
| 03:27 ET | 28574 | 1.135 |
| 03:30 ET | 9738 | 1.136 |
| 03:32 ET | 2381 | 1.13 |
| 03:34 ET | 8188 | 1.13 |
| 03:36 ET | 6749 | 1.13 |
| 03:38 ET | 90156 | 1.14 |
| 03:39 ET | 8256 | 1.14 |
| 03:41 ET | 5400 | 1.145 |
| 03:43 ET | 11078 | 1.145 |
| 03:45 ET | 13042 | 1.145 |
| 03:48 ET | 19826 | 1.14 |
| 03:50 ET | 4080 | 1.14 |
| 03:52 ET | 14487 | 1.14 |
| 03:54 ET | 22216 | 1.145 |
| 03:56 ET | 27017 | 1.145 |
| 03:57 ET | 7734 | 1.14 |
| 03:59 ET | 283715 | 1.14 |
Sep 5, 2024
Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit, from 7:00AM ET on Thursday Sep 05, 2024 by Dow Jones
7:00AM ET on Thursday Sep 05, 2024 by Dow Jones
Sep 3, 2024
Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference, from 7:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
7:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
Aug 28, 2024
Aug 26, 2024
DJ Ocugen Gets Health Canada Approval for Phase 3 Trial of Gene Therapy for Retinitis Pigmentosa, from 7:30AM ET on Monday Aug 26, 2024 by Dow Jones
7:30AM ET on Monday Aug 26, 2024 by Dow JonesOcugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 -- Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication, from 7:02AM ET on Monday Aug 26, 2024 by Dow Jones
7:02AM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocugen Inc | 328.2M | -6.4x | --- |
XOMA Royalty Corp | 319.3M | -12.5x | --- |
Nautilus Biotechnology Inc | 319.8M | -4.6x | --- |
Kyverna Therapeutics Inc | 316.7M | 0.0x | --- |
Solid Biosciences Inc | 313.0M | -2.5x | --- |
Inozyme Pharma Inc | 312.4M | -3.4x | --- |
Company Information
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Contact Information
- Headquarters
- 11 GREAT VALLEY PARKWAYMALVERN, PA, United States 19355
- Phone
- 484-328-4701
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Shankar Musunuri
- Chief Accounting Officer, Controller
- Michael Breininger
- Chief Scientific Officer, Executive Officer, Head of Research and Development
- Arun Upadhyay
- Chief Medical Officer
- Huma Qamar
- Independent Director
- Kirsten Castillo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $328.2M |
|---|---|
Revenue (TTM) | $8.2M |
Shares Outstanding | 287.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.76 |
EPS | $-0.18 |
Book Value | $0.16 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | 40.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -631.33% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
